Baird Maintains Outperform on National Healthcare, Raises Price Target to $18
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Baird analyst Wesley Golladay maintains National Healthcare (NASDAQ:NHP) with a Outperform and raises the price target from $17 to $18.
Baird analyst Wesley Golladay maintains National Healthcare (NASDAQ:NHP) with a Outperform and raises the price target from $17 to $18.